Clinical Trial Update: Creon Use in Coeliac Patients With Low Faecal Pancreatic Elastase [Phase 4]

View source ↗

Summary

A Phase 4 trial update on using Creon in coeliac disease patients with low pancreatic elastase and chronic diarrhea, with terminated status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coeliac Disease
• Diarrhoea

Drugs mentioned

• Creon (pancrelipase)

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Patients With Coeliac Disease and Chronic Diarrhoea (>3 Loose/ Liquid Motions a Day for More Than 4 Weeks), Patients With Pancreatic Exocrine Insufficiency | Phase 4 | Status: TERMINATED